Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haplo-identical Donors”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)Looking for participantsNCT05066412
What this trial is testing

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Who this might be right for
Hematologic MalignancyHaplo-identical Stem Cell Transplantation
University Hospital, Geneva 12
Early research (Phase 1)UnknownNCT04886206
What this trial is testing

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Large-scale testing (Phase 3)Study completedNCT03719534
What this trial is testing

Haplo HCT vs Haplo-cord HCT for Patients With AML

Who this might be right for
Hematopoietic Stem Cell TransplantationHaplo-identical DonorCord Blood Unit+1 more
The First Affiliated Hospital of Soochow University 134
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Not applicableLooking for participantsNCT06734520
What this trial is testing

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)Haplo-identical Donors
Guangzhou Women and Children's Medical Center 3
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableStudy completedNCT05243498
What this trial is testing

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationHaplo-identical
Central Hospital, Nancy, France 80
Early research (Phase 1)Not Yet RecruitingNCT05855707
What this trial is testing

Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis

Who this might be right for
Allogeneic DiseaseGVHD,AcuteGraft Failure
Central Hospital, Nancy, France 12
Testing effectiveness (Phase 2)Study completedNCT02046122
What this trial is testing

Adoptive Transfer of Haplo-identical DLI for AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Duke University 19
Testing effectiveness (Phase 2)Study completedNCT01682226
What this trial is testing

Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic SyndromeLymphoma
Memorial Sloan Kettering Cancer Center 84
Testing effectiveness (Phase 2)Ended earlyNCT02127892
What this trial is testing

SCID Bu/Flu/ATG Study With T Cell Depletion

Who this might be right for
Severe Combined Immunodeficiency
Neena Kapoor, M.D. 9
Not applicableEnded earlyNCT04067180
What this trial is testing

Randomized Clinical Study Assessing Haplo vs. URD in AML

Who this might be right for
Acute Myeloid Leukemia
Karolinska Institutet 18
Testing effectiveness (Phase 2)Study completedNCT04686929
What this trial is testing

Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Who this might be right for
AbataceptAcute-graft-versus-host DiseaseHaplo-identical HCT+1 more
The First Affiliated Hospital of Soochow University 29
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Testing effectiveness (Phase 2)Looking for participantsNCT03670966
What this trial is testing

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia in Remission+9 more
Fred Hutchinson Cancer Center 30
Not applicableStudy completedNCT01793675
What this trial is testing

Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Who this might be right for
Advanced MDS Without Identical Sibling Donor
Peking University People's Hospital 116
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Not applicableLooking for participantsNCT06089850
What this trial is testing

Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors

Who this might be right for
Haplo-identical TransplantationTransplantation
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Early research (Phase 1)Study completedNCT00104975
What this trial is testing

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Yale University 20
Next Page